Untargeted metabolomics to map defects arising in Snyder-Robinson syndrome

Awardee: Ankur Jain

Institution: Whitehead Institute for Biomedical Research

Grant Amount: $74,691

Funding Period: February 1, 2022 - January 31, 2023


Summary:

Snyder-Robinson syndrome (SRS) is a rare, X-linked genetic disorder caused by mutations in the spermine synthase (SMS) gene. In this project, we will examine how this mutation changes the small molecule metabolite composition of the cell. This work may reveal new disease biomarkers, and may potentially inform intervention strategies.

Previous
Previous

Pre-clinical investigation of candidate therapies for NUBPL disease

Next
Next

Measuring neurotransmitter metabolites for biomarker discovery in Mucolipidosis IV